Lidovyx Gel
FDA Label NDC 72835-447

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by V2 Pharma Llc for the product Lidovyx (NDC 72835-447). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding lidovyx, active ingredient, purpose, uses, warnings, directions, storage, inactive ingredients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Lidovyx

Touch free targeted relief

Active Ingredient

Lidocaine HCL 4%

Purpose

Topical Analgesic

Uses

For the temporary relief of pain and itching 

Warnings

For external use only

Avoid contact with eyes

Do not use in large quantities, particularly over raw surfaces or blistered areas

Stop use and ask a doctor if condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days. Discontinue use.

Directions

  • Adults and children 2 years of age and older: apply to affected area not more than 3 to 4 times daily
  • Children under 2 years of age: do not use, consult a physician

Storage

Protect this product from excessive heat and direct sun.

Inactive Ingredients

water, SD alcohol 40-B, aloe barbadensis leaf extract, propylene glycol, triethanolamine, acrylates/C10-30 alkyl acrylate crosspolymer, glycerin, menthol, chamomile extract, calendula extract, green tea extract, comfrey extract, phenoxyethanol, ethylhexylglycerin

Other Information

Manufactured for V2 Pharma, LLC

8210 SW Nimbus Ave.

Beaverton, OR 97008

+1 (800) 519-8334

Principal Display Panel

Lidovyx 

NDC 72835-447-01

* Please review the disclaimer below.